A detailed history of Ridgecrest Wealth Partners, LLC transactions in Pfizer Inc stock. As of the latest transaction made, Ridgecrest Wealth Partners, LLC holds 35,058 shares of PFE stock, worth $937,450. This represents 0.53% of its overall portfolio holdings.

Number of Shares
35,058
Previous 38,577 9.12%
Holding current value
$937,450
Previous $1.08 Million 6.02%
% of portfolio
0.53%
Previous 0.65%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 04, 2024

SELL
$27.7 - $31.39 $97,476 - $110,461
-3,519 Reduced 9.12%
35,058 $1.01 Million
Q2 2024

Aug 05, 2024

SELL
$25.26 - $29.6 $175,152 - $205,246
-6,934 Reduced 15.24%
38,577 $1.08 Million
Q1 2024

Apr 17, 2024

SELL
$25.89 - $29.73 $103,948 - $119,365
-4,015 Reduced 8.11%
45,511 $1.26 Million
Q4 2023

Jan 09, 2024

SELL
$26.13 - $33.94 $72,615 - $94,319
-2,779 Reduced 5.31%
49,526 $1.43 Million
Q3 2023

Oct 25, 2023

SELL
$32.09 - $37.51 $9,627 - $11,253
-300 Reduced 0.57%
52,305 $1.73 Million
Q2 2023

Jul 31, 2023

BUY
$36.12 - $41.79 $6,321 - $7,313
175 Added 0.33%
52,605 $1.93 Million
Q1 2023

Apr 24, 2023

SELL
$39.39 - $51.28 $3,939 - $5,128
-100 Reduced 0.19%
52,430 $2.14 Million
Q4 2022

Jan 26, 2023

SELL
$41.75 - $54.5 $6,262 - $8,175
-150 Reduced 0.28%
52,530 $0
Q3 2022

Oct 20, 2022

SELL
$43.76 - $53.42 $766,631 - $935,864
-17,519 Reduced 24.96%
52,680 $2.31 Million
Q2 2022

Jul 29, 2022

BUY
$46.53 - $55.17 $697 - $827
15 Added 0.02%
70,199 $3.68 Million
Q4 2021

Jan 19, 2022

BUY
$41.32 - $61.25 $170,031 - $252,043
4,115 Added 6.23%
70,184 $4.14 Million
Q3 2021

Nov 03, 2021

BUY
$39.25 - $50.42 $95,377 - $122,520
2,430 Added 3.82%
66,069 $2.84 Million
Q2 2021

Jul 21, 2021

BUY
$35.91 - $40.68 $65,176 - $73,834
1,815 Added 2.94%
63,639 $2.49 Million
Q1 2021

May 19, 2021

BUY
$33.49 - $37.77 $2.07 Million - $2.34 Million
61,824 New
61,824 $2.24 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $150B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Ridgecrest Wealth Partners, LLC Portfolio

Follow Ridgecrest Wealth Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ridgecrest Wealth Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ridgecrest Wealth Partners, LLC with notifications on news.